CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,086,450 | +164.0% | 1,205,000 | +4.3% | 4.58% | +325.1% |
| Q2 2020 | $5,336,000 | +32.0% | 1,155,000 | +10.0% | 1.08% | +0.7% |
| Q1 2020 | $4,043,000 | -56.6% | 1,050,000 | -42.5% | 1.07% | -58.4% |
| Q1 2019 | $9,308,000 | +221.4% | 1,825,000 | +87.2% | 2.58% | +76.1% |
| Q4 2014 | $2,896,000 | -99.9% | 975,000 | 0.0% | 1.46% | -42.0% |
| Q3 2014 | $3,237,000,000 | +92703.9% | 975,000 | -29.3% | 2.52% | -16.1% |
| Q2 2014 | $3,488,000 | +11.9% | 1,378,584 | 0.0% | 3.01% | +30.6% |
| Q1 2014 | $3,116,000 | -99.9% | 1,378,584 | +1.8% | 2.30% | +11.0% |
| Q4 2013 | $2,640,105,000 | – | 1,353,900 | – | 2.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |